";s:4:"text";s:3565:" MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.1 Wall Street analysts have issued ratings and price targets for Evoke Pharma in the last 12 months. View which stocks are hot on social media with MarketBeat's trending stocks report.Identify stocks that meet your criteria using seven unique stock screeners. See Evoke Pharma, Inc. (EVOK) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. The high price target for EVOK is $10.00 and the low price target for EVOK is $10.00. 1 equities research analysts have issued 1 year price targets for Evoke Pharma's stock.
View analysts' price targets for Evoke Pharma. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Evoke Pharma Inc. analyst estimates by MarketWatch. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Find the latest Evoke Pharma, Inc. (EVOK) stock quote, history, news and other vital information to help you with your stock trading and investing. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Their average twelve-month price target is $10.00, predicting that the stock has a possible upside of 98.02%. The chart below shows how a company's share price and consensus price target have changed over time. Data may be intentionally delayed pursuant to supplier requirements. The dark blue line represents the company's actual price.
Their forecasts range from $10.00 to $10.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy." FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy).
Financial Overview. The Company is focused primarily on the development of drugs to treat gastrointestinal (GI) disorders and diseases.
Export data to Excel for your own analysis. Financial Performance. View EVOK revenue estimates and earnings estimates, as well as analyst recommendations. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Evoke Pharma, Inc. is a specialty pharmaceutical company. Learn about financial terms, types of investments, trading strategies and more.MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Get detailed information on Evoke Pharma stock (NASDAQ: EVOK), including today’s stock quote, real-time price, financial history, charts, and more. Get short term trading ideas from the MarketBeat Idea Engine.